Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of nab-paclitaxel monotherapy in
previously treated advanced or metastatic squamous lung cancer.